12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

ABX-CBL murine anti-CD147 monoclonal antibody regulatory update

The FDA granted Orphan Drug designation to ABX-CBL to treat steroid-resistant graft-versus-host disease (GvHD), for which...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >